Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).

The crystal structure of LRH-1 ligand binding domain bound to our previously reported agonist 3-(E-oct-4-en-4-yl)-1-phenylamino-2-phenyl-cis-bicyclo[3.3.0]oct-2-ene 5 is described. Two new classes of agonists in which the bridgehead anilino group from our first series was replaced with an alkoxy or 1-ethenyl group were designed, synthesized, and tested for activity in a peptide recruitment assay. Both new classes gave very active compounds, particularly against SF-1. Structure-activity studies led to excellent dual-LRH-1/SF-1 agonists (e.g., RJW100) as well as compounds selective for LRH-1 (RJW101) and SF-1 (RJW102 and RJW103). The series based on 1-ethenyl substitution was acid stable, overcoming a significant drawback of our original bridgehead anilino-substituted series. Initial studies on the regulation of gene expression in human cell lines showed excellent, reproducible activity at endogenous target genes.

[1]  J. Gustafsson,et al.  Transcriptional corepression by SHP: molecular mechanisms and physiological consequences , 2005, Trends in Endocrinology & Metabolism.

[2]  Takashi Suzuki,et al.  Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer. , 2005, Cancer research.

[3]  Liping Zhao,et al.  Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. , 2008, Molecular endocrinology.

[4]  A. Cooney,et al.  Nuclear Receptors in Regulation of Mouse ES Cell Pluripotency and Differentiation , 2007, PPAR research.

[5]  P. Tontonoz,et al.  Adopting new orphans into the family of metabolic regulators. , 2008, Molecular endocrinology.

[6]  S. Kliewer,et al.  Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. , 2005, Molecular cell.

[7]  A. Lewis,et al.  Molecular aspects of steroidogenic factor 1 (SF-1) , 2010, Molecular and Cellular Endocrinology.

[8]  Jian Zeng,et al.  Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis , 2007, Molecular and Cellular Biochemistry.

[9]  T. Willson,et al.  Chemical genomics: Functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism , 2001, Medicinal research reviews.

[10]  H. Do,et al.  Transcriptional regulation of human Oct4 by steroidogenic factor‐1 , 2007, Journal of cellular biochemistry.

[11]  J. Lehmann,et al.  Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.

[12]  A. Moschetta,et al.  Nuclear receptors, intestinal architecture and colon cancer: an intriguing link , 2008, Cellular and Molecular Life Sciences.

[13]  Y. Murata,et al.  Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy. , 2005, Cancer research.

[14]  Simak Ali,et al.  The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells , 2011, Breast Cancer Research and Treatment.

[15]  R. Heyman,et al.  The flip side: Identifying small molecule regulators of nuclear receptors. , 2004, Chemistry & biology.

[16]  T. Maudelonde,et al.  The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene , 2005, Oncogene.

[17]  Armando Navarro-Vázquez,et al.  A Graphical Tool for the Prediction of Vicinal Proton-Proton 3JHH Coupling Constants , 2004, J. Chem. Inf. Model..

[18]  Masatoshi Nomura,et al.  Atrazine-Induced Aromatase Expression Is SF-1 Dependent: Implications for Endocrine Disruption in Wildlife and Reproductive Cancers in Humans , 2007, Environmental health perspectives.

[19]  E. Dammer,et al.  Steroidogenic factor-1 is a sphingolipid binding protein , 2007, Molecular and Cellular Endocrinology.

[20]  H. Ingraham,et al.  The Herbicide Atrazine Activates Endocrine Gene Networks via Non-Steroidal NR5A Nuclear Receptors in Fish and Mammalian Cells , 2008, PloS one.

[21]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[22]  Johan Auwerx,et al.  LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. , 2004, Trends in cell biology.

[23]  F. D. Leeuw,et al.  The relationship between proton-proton NMR coupling constants and substituent electronegativities—I : An empirical generalization of the karplus equation , 1980 .

[24]  J. Achermann,et al.  Steroidogenic Factor-1 (SF-1, Ad4BP, NR5A1) and Disorders of Testis Development , 2008, Sexual Development.

[25]  J. Auwerx,et al.  Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. , 2004, Molecular cell.

[26]  R. Fletterick,et al.  The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 , 2008, Proceedings of the National Academy of Sciences.

[27]  K. McElreavey,et al.  Mutations in NR5A1 associated with ovarian insufficiency. , 2009, The New England journal of medicine.

[28]  S. Bulun,et al.  Regulation of breast cancer-associated aromatase promoters. , 2009, Cancer letters.

[29]  M. Redinbo,et al.  Orphan nuclear receptors adopted by crystallography. , 2005, Current opinion in structural biology.

[30]  I. Talianidis,et al.  SUMO-Dependent Compartmentalization in Promyelocytic Leukemia Protein Nuclear Bodies Prevents the Access of LRH-1 to Chromatin , 2005, Molecular and Cellular Biology.

[31]  S. Kliewer,et al.  Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of Embryonic Development , 2005, Molecular and Cellular Biology.

[32]  Peter Olson,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0288 Minireview: Lipid Metabolism, Metabolic Diseases, and , 2022 .

[33]  K. Pearce,et al.  The Nuclear Receptor Superfamily and Drug Discovery , 2006, ChemMedChem.

[34]  M. Trauner,et al.  Nuclear receptors as therapeutic targets in cholestatic liver diseases , 2009, British journal of pharmacology.

[35]  P. Val,et al.  SF-1 a key player in the development and differentiation of steroidogenic tissues , 2003, Nuclear receptor.

[36]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[37]  D. Schteingart.  Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists , 2010 .

[38]  Martyn D Winn,et al.  Macromolecular TLS refinement in REFMAC at moderate resolutions. , 2003, Methods in enzymology.

[39]  E. McCabe,et al.  Molecular mechanisms of DAX1 action. , 2004, Molecular genetics and metabolism.

[40]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[41]  Yanhong Shi,et al.  Orphan nuclear receptors in drug discovery. , 2007, Drug discovery today.

[42]  H. Schägger,et al.  Blue native PAGE , 2006, Nature Protocols.

[43]  Takashi Suzuki,et al.  Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis. , 2006, Cancer letters.

[44]  F. Bergeron,et al.  The nuclear receptors SF1 and LRH1 are expressed in endometrial cancer cells and regulate steroidogenic gene transcription by cooperating with AP-1 factors. , 2009, Cancer letters.

[45]  R. Santen,et al.  History of aromatase: saga of an important biological mediator and therapeutic target. , 2009, Endocrine reviews.

[46]  P. Griffin,et al.  Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening , 2008, Molecular Pharmacology.

[47]  R. Whitby,et al.  Tandem insertion of halocarbenoids and lithium acetylides into zirconacycles: a novel rearrangement to zirconium alkenylidenates by β-addition to an alkynyl zirconocene. , 2011, Chemistry.

[48]  T. Yanase,et al.  Herbicide atrazine activates SF-1 by direct affinity and concomitant co-activators recruitments to induce aromatase expression via promoter II. , 2007, Biochemical and biophysical research communications.

[49]  Janet Hager,et al.  Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP , 2005, Nature Structural &Molecular Biology.

[50]  Liping Zhao,et al.  Central nervous system-specific knockout of steroidogenic factor 1 , 2009, Molecular and Cellular Endocrinology.

[51]  S. Kliewer,et al.  Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. , 2008, Molecular endocrinology.

[52]  Yuriy L Orlov,et al.  The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. , 2010, Cell stem cell.

[53]  H. Ingraham,et al.  The DEAD-Box Protein DP103 (Ddx20 or Gemin-3) Represses Orphan Nuclear Receptor Activity via SUMO Modification , 2005, Molecular and Cellular Biology.

[54]  E. Dammer,et al.  Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. , 2006, Endocrinology.

[55]  T. Willson,et al.  Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1 , 2005, Cell.

[56]  Ilka Wittig,et al.  Advantages and limitations of clear‐native PAGE , 2005, Proteomics.

[57]  Vincent Laudet,et al.  International Union of Pharmacology. LXVI. Orphan Nuclear Receptors , 2006, Pharmacological Reviews.

[58]  D. Moore,et al.  Liver receptor homolog-1, an emerging metabolic modulator. , 2008, Frontiers in bioscience : a journal and virtual library.

[59]  B. Goodwin,et al.  Liver Receptor Homolog 1 Is a Negative Regulator of the Hepatic Acute-Phase Response , 2006, Molecular and Cellular Biology.

[60]  R. Stauber,et al.  Therapeutic potential of nuclear receptors , 2008 .

[61]  Austin G Smith,et al.  A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency , 2010, Development.

[62]  R. Whitby,et al.  A rearrangement to a zirconium-alkenylidene in the insertion of dihalocarbenoids and acetylides into zirconacycles. , 2006, Angewandte Chemie.

[63]  S. Mani,et al.  Orphan Nuclear Receptors as Targets for Drug Development , 2010, Pharmaceutical Research.

[64]  P. Yin,et al.  Steroidogenic factor-1 and endometriosis , 2009, Molecular and Cellular Endocrinology.

[65]  S. Bulun,et al.  Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. , 2009, Cancer research.

[66]  Supplemental Information The Nuclear Receptor Nr 5 a 2 Can Replace Oct 4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells , 2009 .

[67]  P. Hodder,et al.  Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds. , 2008, Bioorganic & medicinal chemistry letters.

[68]  Martin Karplus,et al.  Vicinal Proton Coupling in Nuclear Magnetic Resonance , 1963 .

[69]  J. Gustafsson,et al.  EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation , 2005, Nucleic acids research.

[70]  J. Auwerx,et al.  Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[72]  E. Husebye,et al.  Immunology of Addison's disease and premature ovarian failure. , 2009, Endocrinology and metabolism clinics of North America.

[73]  E. Dammer,et al.  Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3',5'-monophosphate-dependent cytochrome P450c17 transcription rate. , 2007, Molecular endocrinology.

[74]  Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. , 2010, Molecular endocrinology.

[75]  Richard J Whitby,et al.  Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. , 2006, Journal of medicinal chemistry.

[76]  C. Agulló,et al.  Stereoselective synthesis of (-)-metasequoic acid B , 1997 .

[77]  R. Fletterick,et al.  Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. , 2009, Molecular endocrinology.

[78]  S. Castillón,et al.  Synthesis of Purine and Pyrimidine Isodideoxynucleosides from (S)-Glycydol Using Iodoetherification as Key Step. Synthesis of (S,S)-iso-ddA1 , 1999 .

[79]  D. Moore,et al.  Phosphorylation of the Hinge Domain of the Nuclear Hormone Receptor LRH-1 Stimulates Transactivation* , 2006, Journal of Biological Chemistry.